Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
Patient centricity in pharma

The Evolving State of Patient Centricity in the Pharmaceutical Industry

Patient centricity has been a point of discussion in pharma for years. Learn what patient...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging technology for patient centricity

Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs

As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
MSL-KOL relationship

Reimagining the MSL-KOL Relationship

MSL-KOL relationships: Medical Affairs teams and KOLs believe that approximately 40-50% of future interactions will...
Medical Affairs

The Changing Environment of Medical Affairs and Need for Increased Customer-Centricity

Medical Affairs will soon emerge as a frontline strategic division and grow in stature as...

Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences

The growth and adoption of the internet and mobile technology have provided publishers and authors...

Learn more ABOUT our company.